Literature DB >> 29633053

Total iron-binding capacity is a novel prognostic marker after curative gastrectomy for gastric cancer.

Hiroshi Sawayama1, Masaaki Iwatsuki1, Daisuke Kuroda1, Tasuku Toihata1, Tomoyuki Uchihara1, Yuki Koga1, Taisuke Yagi1, Yuki Kiyozumi1, Tsugio Eto1, Yukiharu Hiyoshi1, Takatsugu Ishimoto1, Yoshifumi Baba1, Yuji Miyamoto1, Naoya Yoshida1, Hideo Baba2.   

Abstract

BACKGROUND: Patients with gastric cancer (GC) are affected by changes in iron status. Before surgery, GC patients are likely to have iron-deficiency anemia; and after gastrectomy, patients suffer from low nutritional status and low iron. This study investigated preoperative iron status associated with prognosis after curative gastrectomy for gastric cancer.
METHODS: We evaluated preoperative serum hemoglobin (Hgb), Fe and total iron-binding capacity (TIBC) in 298 patients who underwent curative gastrectomy for GC without preoperative chemotherapy, and analyzed these factors' associations with prognosis after surgery.
RESULTS: Of the 298 patients, 129 (43.2%) had low Hgb levels, and 33 (11.1%) had low TIBC (< 260 µg/dl) that was not associated with Hgb or Fe level. Patients with low TIBC were significantly associated with older age (≥ 65 years old; P = 0.0085), low albumin (< 3.9 g/dl; P = 0.0388) and high CRP (≥ 0.15 mg/dl; P = 0.0018) in multivariate analysis. Low Fe (< 60 µg/dl) was not associated with disease-free survival (DFS) or overall survival (OS); however, low Fe was associated with longer cancer-specific survival in Stage III GC patients (P = 0.0333). Both low Hgb and low TIBC were significantly associated with shorter DFS (Hgb: P = 0.0433; TIBC: P < 0.0001) and shorter OS (Hgb: P = 0.0352; TIBC: P < 0.0001). Low TIBC were significantly associated with shorter DFS (HR 2.167, 95% CI 1.231-3.639, P = 0.0086) and shorter OS (HR 2.065, 95% CI 1.144-3.570, P = 0.0173) in multivariate Cox hazard regression analysis.
CONCLUSIONS: Preoperative serum TIBC level of GC patients who undergo curative gastrectomy is a novel prognostic marker in univariate and multivariate analyses.

Entities:  

Keywords:  Fe; Iron status; Prognosis; TIBC

Mesh:

Substances:

Year:  2018        PMID: 29633053     DOI: 10.1007/s10147-018-1274-7

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  34 in total

1.  Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition.

Authors:  Yoshiki Okamoto; Keiichi Okano; Kunihiko Izuishi; Hisashi Usuki; Hisao Wakabayashi; Yasuyuki Suzuki
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

2.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection.

Authors:  Daisuke Kuroda; Hiroshi Sawayama; Junji Kurashige; Masaaki Iwatsuki; Tsugio Eto; Ryuma Tokunaga; Yuki Kitano; Kensuke Yamamura; Mayuko Ouchi; Kenichi Nakamura; Yoshifumi Baba; Yasuo Sakamoto; Yoichi Yamashita; Naoya Yoshida; Akira Chikamoto; Hideo Baba
Journal:  Gastric Cancer       Date:  2017-06-27       Impact factor: 7.370

4.  Prospective randomized trial of preoperative enteral immunonutrition followed by elective total gastrectomy for gastric cancer.

Authors:  K Fujitani; T Tsujinaka; J Fujita; I Miyashiro; H Imamura; Y Kimura; K Kobayashi; Y Kurokawa; T Shimokawa; H Furukawa
Journal:  Br J Surg       Date:  2012-02-24       Impact factor: 6.939

5.  A meta-analysis of n-3 polyunsaturated fatty acids effects on circulating acute-phase protein and cytokines in gastric cancer.

Authors:  Michel C Mocellin; Ricardo Fernandes; Thayz R Chagas; Erasmo B S M Trindade
Journal:  Clin Nutr       Date:  2017-05-13       Impact factor: 7.324

6.  Method of reconstruction governs iron metabolism after gastrectomy for patients with gastric cancer.

Authors:  Joong Ho Lee; Woo Jin Hyung; Hyoung-Il Kim; Yoo-Min Kim; Taeil Son; Naoki Okumura; Yanfeng Hu; Choong-Bai Kim; Sung Hoon Noh
Journal:  Ann Surg       Date:  2013-12       Impact factor: 12.969

Review 7.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

8.  Correlations of Hemoglobin Level and Perioperative Blood Transfusion with the Prognosis of Gastric Cancer: A Retrospective Study.

Authors:  Gang Wu; Dai-Yang Zhang; Yu-Han Duan; Ying-Qiong Zhang; Xian-Nian Cui; Zheng Luo
Journal:  Med Sci Monit       Date:  2017-05-23

9.  REporting recommendations for tumour MARKer prognostic studies (REMARK).

Authors:  L M McShane; D G Altman; W Sauerbrei; S E Taube; M Gion; G M Clark
Journal:  Br J Cancer       Date:  2005-08-22       Impact factor: 7.640

10.  Japanese gastric cancer treatment guidelines 2014 (ver. 4).

Authors: 
Journal:  Gastric Cancer       Date:  2016-06-24       Impact factor: 7.370

View more
  6 in total

1.  The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study.

Authors:  Ali Yılmaz; Cem Mirili; Salim Başol Tekin; Mehmet Bilici
Journal:  Ir J Med Sci       Date:  2019-12-12       Impact factor: 1.568

2.  Transferrin Insufficiency and Iron Overload in Follicular Fluid Contribute to Oocyte Dysmaturity in Infertile Women With Advanced Endometriosis.

Authors:  Anji Li; Zhexin Ni; Jie Zhang; Zailong Cai; Yanping Kuang; Chaoqin Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-19       Impact factor: 5.555

3.  Proteomic Alterations in Multiple Myeloma: A Comprehensive Study Using Bone Marrow Interstitial Fluid and Serum Samples.

Authors:  Venkatesh Chanukuppa; Ravindra Taware; Khushman Taunk; Tathagat Chatterjee; Sanjeevan Sharma; Venkatesan Somasundaram; Faraz Rashid; Dipankar Malakar; Manas K Santra; Srikanth Rapole
Journal:  Front Oncol       Date:  2021-01-29       Impact factor: 6.244

Review 4.  Minerals and Cancer: Overview of the Possible Diagnostic Value.

Authors:  Sascha Venturelli; Christian Leischner; Thomas Helling; Olga Renner; Markus Burkard; Luigi Marongiu
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.639

5.  Efficacy and Safety of Daprodustat Vs rhEPO for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis.

Authors:  Zhangning Fu; Xiaodong Geng; Kun Chi; Chengcheng Song; Di Wu; Chao Liu; Quan Hong
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

6.  Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence.

Authors:  Grzegorz Mariusz Sukiennicki; Wojciech Marciniak; Magdalena Muszyńska; Piotr Baszuk; Satish Gupta; Katarzyna Białkowska; Katarzyna Jaworska-Bieniek; Katarzyna Durda; Marcin Lener; Sandra Pietrzak; Tomasz Gromowski; Karolina Prajzendanc; Alicja Łukomska; Piotr Waloszczyk; Janusz Zenon Wójcik; Rodney Scott; Jan Lubiński; Anna Jakubowska
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.